Authors: Zhang H et al. Journal: Anesthesiology. December 29, 2025. SummaryThis two-center retrospective cohort study evaluated whether adding a single-injection peripheral nerve block (PNB) to general or neuraxial anesthesia is associated with a lower risk of postoperative myocardial injury in older adults with high cardiac risk undergoing hip fracture surgery. The investigators included 1,467 patients […]
Read MoreAuthor: Cameron Cortigiano Becker’s ASC Review The average salary for CRNAs in the U.S. ranges between $220,000 and more than $350,000 based on a recent report from BagMask.com. The report, “CRNA Salary by State for 2025 Q4,” is based on advertised compensation ranges for CRNA positions. The average advertised salary is above $300,000 in Alaska, Arizona, California, Iowa, […]
Read MoreAuthor:: Francesca Mathewes Becker’s ASC Review Anesthesia leaders face a diverse set of challenges in 2026 as the workforce shortage continues to shift across geographies, markets and practice settings. Melissa Croad, CRNA, APRN, president of the Massachusetts Association of Nurse Anesthesiology, recently joined Becker’s to discuss how her organization will approach the anesthesia provider shortage in the year ahead. Editor’s […]
Read MoreAuthor: Patsy Newitt Becker’s ASC Review As private equity, MSOs and hospitals continue to expand their presence in ASCs, ownership models are becoming more complex. Tina DiMarino, CEO of Custom Surgical Partners, joined Becker’s to discuss how joint ventures, specialty rollups and increased investor activity are reshaping the ASC landscape. Custom Surgical Partners, an ASC development company […]
Read MoreAuthors: Beukers A et al. Anesthesia & Analgesia, Volume 142, Issue 1, pages 5–14, January 2026 Summary:This narrative review synthesizes how cardiopulmonary bypass (CPB) alters the pharmacokinetics (PK) and pharmacodynamics (PD) of commonly used continuously administered anesthetic and analgesic drugs during on-pump cardiac surgery, and why those shifts can translate into clinically meaningful under- or […]
Read MoreAuthors: Cheng S et al. Anesthesia & Analgesia, Volume 142, Issue 1, pages 19–27, January 2026 Summary:This randomized, blinded noninferiority trial evaluated whether intrathecal hydromorphone is noninferior to intrathecal morphine for postcesarean delivery analgesia when both are administered at their previously established ED90 doses. Given ongoing concerns regarding morphine-related side effects and intermittent drug shortages, […]
Read MoreAuthors: Dragovic SZ et al. Anesthesia & Analgesia, Volume 142, Issue 2, pages 249–260, February 2026 Summary:This retrospective study examines whether commonly used processed EEG metrics obscure meaningful differences between anesthetic agents, particularly propofol versus volatile fluranes (sevoflurane and desflurane). The authors challenge the “one-size-fits-all” assumption that equivalent processed EEG targets reflect comparable anesthetic brain […]
Read MoreAuthors: Kong H et al. Journal: Anesthesiology, November 25, 2025. DOI: 10.1097/ALN.0000000000005778 SummaryThis randomized, double-blind, placebo-controlled trial evaluated whether preemptive magnesium sulfate infusion improves intraoperative hemodynamic stability during pheochromocytoma and paraganglioma (PPGL) resection—procedures well known for extreme catecholamine-mediated blood pressure and heart rate fluctuations. Ninety-two patients scheduled for PPGL resection were randomized to receive either […]
Read MoreAuthor: Sophie Eydis Becker’s ASC Review Anesthesiology saw a year of significant innovation in 2025 as new technologies, techniques and care models redefined what is possible in the perioperative environment. From AI-driven automation to next-generation pain control, five breakthroughs in particular helped shape the specialty. 1. AI-driven decision support, smart ultrasound and virtual reality-enhanced training […]
Read MoreAuthors: Kwon H-M et al. Journal: Anesthesiology, December 2, 2025. DOI: 10.1097/ALN.0000000000005747 SummaryThis retrospective registry-based study evaluated whether incorporating cardiac biomarkers into existing risk models improves prediction of post–liver transplant mortality in patients with acute-on-chronic liver failure (ACLF). Cardiovascular complications are the leading cause of death after liver transplantation in this population, yet commonly used […]
Read More